Detalhe da pesquisa
1.
Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
JAMA
; 328(13): 1304-1314, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194218
2.
Sigmoid Emax Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime.
Antimicrob Agents Chemother
; 65(8): e0092621, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097479
3.
Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253212
4.
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-ß-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253209
5.
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel ß-Lactamase Inhibitor Enmetazobactam.
J Clin Microbiol
; 57(8)2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31167844
6.
Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109163
7.
Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis-Reply.
JAMA
; 329(8): 685, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853252
8.
Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!
Antimicrob Agents Chemother
; 66(4): e0021322, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323013
9.
Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Infection.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784674
10.
Effects of Oritavancin on Coagulation Tests in the Clinical Laboratory.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956417
11.
Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State.
Antimicrob Agents Chemother
; 60(7): 4342-5, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067327
12.
Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates.
J Glob Antimicrob Resist
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723712
13.
Pharmacodynamics of a simulated single 1,200-milligram dose of oritavancin in an in vitro pharmacokinetic/pharmacodynamic model of methicillin-resistant staphylococcus aureus infection.
Antimicrob Agents Chemother
; 57(1): 205-11, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23089749
14.
Impact of surfactants and other body fluids on in vitro activity of a novel ß-lactamase inhibitor enmetazobactam in combination with cefepime against clinical isolates of Klebsiella pneumoniae.
J Antibiot (Tokyo)
; 76(3): 183-189, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690707
15.
Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
J Antimicrob Chemother
; 72(2): 622-624, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856721
16.
Strain-specific differences in the genetic control of two closely related mycobacteria.
PLoS Pathog
; 6(10): e1001169, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21060820
17.
Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of ß-lactamases and comparative in vitro activity of cefepime/enmetazobactam.
J Glob Antimicrob Resist
; 25: 93-101, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33746112
18.
Assessment of oritavancin serum protein binding across species.
Antimicrob Agents Chemother
; 54(8): 3481-3, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20498314
19.
Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing.
Antimicrob Agents Chemother
; 54(12): 5369-71, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20876372
20.
Ultrastructural effects of oritavancin on methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Antimicrob Agents Chemother
; 53(2): 800-4, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19029329